Time-lapse.

Here’s an intriguing review on how CRISPR technology is fast-tracking Big Pharma’s next billion dollar investment by systematically reviewing the impact of deleting each and every 18K-some-odd cancer cell-line genes one at a time. | Hahn, N Engl J Med 2019